Flagship Pioneering forges ahead with $618M capital raise
The capital raise is the culmination of a year that was punctuated with two of its portfolio companies filing initial public offerings and the hire of J.P. Morgan veteran Stephen Berenson.
New partnerships aims to unlock mysteries of traumatic brain injury
Quanterix and Banyan Biomarkers want to study two proteins about which not much is known but that show up in the blood when humans take a blow to their head.
NEMT Partner Guide: Why Payers and Providers Should Choose MediDrive’s TMS
Alan Murray on improving access for medical transportation.
Quanterix Raises $46M in Series D to expand its single molecule testing capabilities
Utilizing liquid biopsies and other forms of early detection are integral in Quanterix' technology designed to help detect disease before symptoms are even present.